Autifony Therapeutics Ltd

Autifony Therapeutics aims to develop new drugs using pioneering science to treat hearing disorders and serious disorders of the central nervous system which represent major unmet medical needs.
By targeting specific ion channels which regulate neuronal activity, our new small molecule drugs will help to alleviate symptoms of Schizophrenia, Fragile X, Alzheimer’s Disease and reduce symptoms associated with hearing loss.